Lotensin
NDC 54868-2352
Product Information
Lotensin is a NDA-approved product labeled by Physicians Total Care, Inc.. Benazepril is used to treat high blood pressure (hypertension). It is supplied as a yellow product. This product entry covers the primary NDC 54868-2352 and 2 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
YELLOW (C48330 - DARK YELLOW)
PINK (C48328)
RED (C48326 - DARK ROSE)
LOTENSIN;5
LOTENSIN;10
LOTENSIN;20
LOTENSIN;40
Code Structure Chart
Product Details
What is NDC 54868-2352?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- BENAZEPRIL HYDROCHLORIDE (UNII: N1SN99T69T)
- BENAZEPRILAT (UNII: JRM708L703) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- CROSPOVIDONE (UNII: 68401960MK)
- HYDROGENATED CASTOR OIL (UNII: ZF94AP8MEY)
- HYPROMELLOSES (UNII: 3NXW29V3WO)
- LACTOSE (UNII: J2B2A4N98G)
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- POLYSORBATE 80 (UNII: 6OZP39ZG8H)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- STARCH, POTATO (UNII: 8I089SAH3T)
- TALC (UNII: 7SEV7J4R1U)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 898687 - benazepril HCl 10 MG Oral Tablet
- RxCUI: 898687 - benazepril hydrochloride 10 MG Oral Tablet
- RxCUI: 898687 - BZP hydrochloride 10 MG Oral Tablet
- RxCUI: 898689 - Lotensin 10 MG Oral Tablet
- RxCUI: 898689 - benazepril hydrochloride 10 MG Oral Tablet [Lotensin]
* Please review the full disclaimer at the bottom of this page.